EI
ADVM

Ellevest Inc’s Adverum Biotechnologies ADVM Stock Holding History

Ellevest Inc’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12
Closed – – 1384
2021
Q4 		$0 Buy
+12
New +$240 ﹤0.01% 1382

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ellevest Inc's ADVM Position: Q1 2022 in Review

Ellevest Inc sold out of Adverum Biotechnologies (ADVM) in Q1 2022, closing a stake of 12 shares.

Ellevest Inc first reported a position in ADVM in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 92 funds tracked by Wall St. Rank hold ADVM as of Q1 2022.

  • Ellevest Inc reported no remaining Adverum Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Ellevest Inc sold 12 Adverum Biotechnologies shares in Q1 2022.
  • Ellevest Inc first reported a position in Adverum Biotechnologies in Q4 2021 and held it in 1 quarter.
  • Ellevest Inc's Adverum Biotechnologies position peaked at $0 in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2022.

Based on Ellevest Inc's 13F filing for Q1 2022, filed 19 Apr 2022.